Compounds > 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one
Page last updated: 2024-10-21

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Peripheral Nerve Diseases

1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one has been researched along with Peripheral Nerve Diseases in 1 studies

1H-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one: structure given in first source; inhibits guanylyl cyclase
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one : A member of the class of oxadiazoloquinoxalines that is 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline substituted at position 1 by an oxo group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Romero, TR1
Galdino, GS1
Silva, GC1
Resende, LC1
Perez, AC1
Côrtes, SF1
Duarte, ID1

Other Studies

1 other study available for 1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one and Peripheral Nerve Diseases

ArticleYear
Ketamine activates the L-arginine/Nitric oxide/cyclic guanosine monophosphate pathway to induce peripheral antinociception in rats.
    Anesthesia and analgesia, 2011, Volume: 113, Issue:5

    Topics: Analgesia; Anesthetics, Dissociative; Animals; Arginine; Cyclic AMP; Dinoprostone; Drug Synergism; E

2011